NVX vs PAMT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
NVX exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 3/9 and a catastrophic operating margin of -920.61%. While the company maintains a decent gross margin of 55.49%, this is completely offset by massive operational inefficiencies and a declining revenue growth rate of -10.10%. The stock is trading at an exorbitant Price/Sales ratio of 33.37, indicating a massive valuation disconnect from its current fundamental performance. With a 5-year price collapse of 96.4% and a bearish technical trend, the company appears to be in a speculative death spiral despite a lone analyst's optimistic target price.
PAMT exhibits severe financial distress, anchored by a weak Piotroski F-Score of 2/9 and a catastrophic year-over-year EPS decline of 369.2%. While the stock appears cheap on a Price-to-Book (0.94) and Price-to-Sales (0.33) basis, these metrics are overshadowed by negative operating margins (-29.82%) and shrinking revenues (-15.10%). The company has transitioned from a period of profitability (2021-2023) into a consistent loss-making cycle with significant earnings misses. The combination of deteriorating fundamentals and a 0/100 technical trend suggests a value trap rather than a value opportunity.
Compare Another Pair
Related Comparisons
NVX vs PAMT: Head-to-Head Comparison
This page compares NOVONIX Limited (NVX) and PAMT CORP (PAMT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.